Enterocolitis Clinical Trials

27 recruitingLast updated: June 17, 2026

There are 27 actively recruiting enterocolitis clinical trials across 14 countries. Studies span Not Applicable, Phase 1, Early Phase 1, Phase 2, Phase 3. Top locations include London, United Kingdom, Liverpool, United Kingdom, Clermont-Ferrand, France. Updated daily from ClinicalTrials.gov.


Enterocolitis Trials at a Glance

27 actively recruiting trials for enterocolitis are listed on ClinicalTrialsFinder across 6 cities in 14 countries. The largest study group is Not Applicable with 11 trials, with the heaviest enrollment activity in London, Liverpool, and Clermont-Ferrand. Lead sponsors running enterocolitis studies include Rigshospitalet, Denmark, BiomeBank, and Baskent University Ankara Hospital.

Browse enterocolitis trials by phase

Treatments under study

About Enterocolitis Clinical Trials

Looking for clinical trials for Enterocolitis? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Enterocolitis trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Enterocolitis clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 27 trials

Recruiting
Not Applicable

Immunologic Basis of Food Protein-Induced Enterocolitis Syndrome

Food Protein Induced Enterocolitis Syndrome
NYU Langone Health72 enrolled2 locationsNCT06683521
Recruiting
Not Applicable

WithHolding Enteral Feeds Around Blood Transfusion (International)

Necrotizing Enterocolitis
IWK Health Centre4,333 enrolled40 locationsNCT05213806
Recruiting
Phase 1Phase 2

Study to Assess the Safety, Tolerability, and Preliminary Efficacy of ST266 in Infants With Necrotizing Enterocolitis (NEC)

Necrotizing Enterocolitis
Noveome Biotherapeutics, formerly Stemnion36 enrolled8 locationsNCT06315738
Recruiting
Not Applicable

Predictive Diagnosis of Ulcero-Necrotizing EnteroColitis in Premature Babies Using an Artificial Intelligence Approach Based on Early Analysis of the Fecal Microbiota

Healthy ControlNecrotizing Enterocolitis (NEC)
University Hospital, Clermont-Ferrand1,000 enrolled5 locationsNCT06727877
Recruiting

Health-Related Quality-of-Life and Household Financial and Wellbeing Impacts of Prematurity and Necrotising Enterocolitis (NEC).

Necrotising EnterocolitisPreterm BirthPreterm+3 more
Imperial College London90 enrolled7 locationsNCT07192393
Recruiting

Mechanisms Affecting the Gut of Preterm Infants Receiving Blood Transfusion With Different Enteral Feed Interventions

Preterm BabiesNECNEC - Necrotizing Enterocolitis+1 more
Imperial College Healthcare NHS Trust270 enrolled1 locationNCT07191678
Recruiting

Study of Normal Intestinal Development and Disease in Premature and Term Neonates

Necrotizing EnterocolitisIntestinal DiseaseNEC+1 more
Boston Children's Hospital100 enrolled1 locationNCT06681129
Recruiting

Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With Severe Morbidity and Mortality

Intraventricular hemorrhageDeathPulmonary Hemorrhage+5 more
University Hospital, Montpellier30 enrolled1 locationNCT07273643
Recruiting

NETs: Protection or Harm in Neonatal Inflammation or Infection

Necrotizing Enterocolitis (NEC)
University of Utah388 enrolled1 locationNCT00747851
Recruiting
Phase 1

A Study of SER-155 to Treat Diarrhea in People on Immunotherapy

DiarrheaEnterocolitis
Memorial Sloan Kettering Cancer Center15 enrolled7 locationsNCT06801067
Recruiting

Amniotic Fluid & the Preterm Gut

ChorioamnionitisFetal Growth Restriction (FGR)Neonatal Sepsis, Late-Onset+5 more
Maxima Medical Center275 enrolled2 locationsNCT07152106
Recruiting

Early Predictors of Necrotizing Enterocolitis in Neonates

Necrotizing Enterocolitis
Nationwide Children's Hospital450 enrolled1 locationNCT03210831
Recruiting

The Intestinal Innate Immune System in Newborns. Development and Inflammation in Health and Disease

Preterm infantsNecrotising EnterocolitisTerm Infants+2 more
Rigshospitalet, Denmark275 enrolled2 locationsNCT06092463
Recruiting
Not Applicable

Primary Anastomosis Versus Enterostomy in the Surgical Treatment of Necrotising Enterocolitis

Necrotizing Enterocolitis
The University of Hong Kong90 enrolled1 locationNCT04912453
Recruiting
Early Phase 1

PrePhage - Faecal Bacteriophage Transfer for Enhanced Gastrointestinal Tract Maturation in Preterm Infants

Necrotizing EnterocolitisMicrobial Substitution
Rigshospitalet, Denmark20 enrolled1 locationNCT05272579
Recruiting
Not Applicable

Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study

Necrotizing EnterocolitisRetinopathy of PrematurityBreast Feeding+2 more
Baskent University Ankara Hospital120 enrolled1 locationNCT06672913
Recruiting
Not Applicable

Safety and Efficacy of Fecal Microbiota Transplantation

AlopeciaDiabetes MellitusObesity+24 more
Chinese University of Hong Kong450 enrolled1 locationNCT04014413
Recruiting
Not Applicable

Spectral Analysis of Bowel Sounds in Preterm Babies of Less Than 32 Weeks of Amenorrhea (WA) as Predictive Factor of Enterocolitis

Preterm BabiesNecrotizing EnterocolitisBowel Sounds+1 more
Centre Hospitalier Universitaire, Amiens50 enrolled1 locationNCT05544097
Recruiting

Qualitative Study of Surgeons With Prospective Patient Follow-up

Necrotizing Enterocolitis
University Hospital Southampton NHS Foundation Trust75 enrolled1 locationNCT06032676
Recruiting
Not Applicable

Probiotic Supplementation in Extremely Preterm Infants in Scandinavia

Necrotizing EnterocolitisDeathSepsis Newborn+2 more
Region Stockholm1,600 enrolled1 locationNCT05604846